Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Retin Cases Brief Rep ; 15(3): 286-288, 2021 May 01.
Article in English | MEDLINE | ID: mdl-30074571

ABSTRACT

PURPOSE: To draw attention to a novel treatment agent for vision loss associated with peripheral exudative hemorrhagic chorioretinopathy. METHODS: The case of an 83-year-old man suffering with loss of left visual acuity vision in the context of vitreous hemorrhage secondary to peripheral exudative hemorrhagic chorioretinopathy is described. RESULTS: Resolution of vitreous hemorrhage and subretinal hemorrhage was demonstrated after treatment with aflibercept. CONCLUSION: Peripheral exudative hemorrhagic chorioretinopathy is discussed in terms of its presentation, pathophysiology, and existing treatment methodologies.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Central Serous Chorioretinopathy/drug therapy , Receptors, Vascular Endothelial Growth Factor/therapeutic use , Recombinant Fusion Proteins/therapeutic use , Retinal Hemorrhage/drug therapy , Vitreous Hemorrhage/drug therapy , Aged, 80 and over , Central Serous Chorioretinopathy/diagnosis , Central Serous Chorioretinopathy/physiopathology , Exudates and Transudates , Humans , Intravitreal Injections , Male , Retinal Hemorrhage/diagnosis , Retinal Hemorrhage/physiopathology , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Visual Acuity/physiology , Vitreous Hemorrhage/diagnosis , Vitreous Hemorrhage/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...